Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
- Orrin Devinsky
- , Chloe Verducci
- , Elizabeth A. Thiele
- , Linda C. Laux
- , Anup D. Patel
- , Francis Filloux
- , Jerzy P. Szaflarski
- , Angus Wilfong
- , Gary D. Clark
- , Yong D. Park
- , Laurie E. Seltzer
- , E. Martina Bebin
- , Robert Flamini
- , Robert T. Wechsler
- , Daniel Friedman
Research output: Contribution to journal › Article › peer-review
175
Link opens in a new tab
Scopus
citations